Skip to main content
Clinical Trials/CTRI/2019/07/020215
CTRI/2019/07/020215
Not yet recruiting
未知

International Multi-Center Observational Study of Lung-protective Ventilation in Asian ICUs.

Tata Memorial Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: J969- Respiratory failure, unspecified
Sponsor
Tata Memorial Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Age above 18
  • 2\.Patients who are admitted to intensive care unit and are on invasive mechanical ventilation.
  • 3\.Patients on mandatory breath setting; either pressure controlled ventilation (PCV) or volume controlled ventilation (VCV).

Exclusion Criteria

  • 1\.Age under 18
  • 2\.Patients other than mandatory breath setting

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
International Multi-Center Observational Study of Lung-protective Ventilation in Asian ICUsDiseases of th respiratory system
KCT0004270Asan Medical Center1,000
Recruiting
Not Applicable
International multicenter observational study to determine the diagnostic sensitivity of plasma metanephrines and urinary catecholamines and metabolites compared to standard evaluation procedures in children with high risk neuroblastoma
NL-OMON51513Centre Hospitalier Universitaire Vaudois-CHUV30
Completed
Not Applicable
YAK.1.C.A: The colonisation of the intestine in childre
ISRCTN66704989Yakult Honsha European Research Center111
Completed
Not Applicable
An International Multi-Center Cohort Study of the Incidence of Anesthesia Awareness Following Laryngoscopy and IntubatioanesthesieIntraoperative AwarenessIntraoperative Complications
NL-OMON42193anesthesiologie- onderzoeksbureau25
Active, not recruiting
Not Applicable
A randomized, international, multi centre study to assess the efficacy and safety of intravenous PEG-liposomal prednisolone sodium phosphate (Nanocort®) vs intravenous methylprednisolone (Solu-Medrol®) treatment in patients with acute exacerbation of relapsing-remitting Multiple Sclerosis or in patients with clinically isolated syndrome (CIS)Patients with acute exacerbation of Relapsing-Remitting Multiple Sclerosis or Clinically Isolated SyndromeMedDRA version: 14.0Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2009-013884-21-DEEnceladus Pharmaceuticals BV90